Henry Ji
Chief Executive Officer chez SORRENTO THERAPEUTICS, INC.
Fortune : 1 M $ au 31/03/2024
Provenance du réseau au premier degré de Henry Ji
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 58 | |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA.
19
| Subsidiary | Pharmaceuticals: Major | 19 |
| Public Company | Pharmaceuticals: Other | 14 | |
Quikbyte Software, Inc.
 Quikbyte Software, Inc. Financial ConglomeratesFinance The Company is develops and markets Computere Software.The Company was Founded in 1989 and it's Headquartered is in Miami,FL.
12
| Extinct | Financial Conglomerates | 12 |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ.
12
| Subsidiary | Miscellaneous Commercial Services | 12 |
| Extinct | Biotechnology | 11 | |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Elsie Biotechnologies Inc.
 Elsie Biotechnologies Inc. BiotechnologyHealth Technology Elsie Biotechnologies Inc. is a private company located in California that is focused on utilizing RNA therapeutics to treat diseases that were previously considered undruggable. The American company's platform enables the synthesis, deconvolution, and delivery of homogeneous oligonucleotide therapeutics. The company was founded in 2021 by Philip E. Dawson and Phil Baran, and the CEO is Kyle Jenne.
5
| Private Company | Biotechnology | 5 |
| Subsidiary | Biotechnology | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Henry Ji via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO Sales & Marketing Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | General Counsel Corporate Officer/Principal | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer General Counsel | |
| ERBA DIAGNOSTICS, INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| SEQUENOM, INC. | Medical Specialties | Director/Board Member Director of Finance/CFO Chief Executive Officer | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director of Finance/CFO President | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| NANTHEALTH, INC. | Packaged Software | Director/Board Member General Counsel | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Brown University | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director of Finance/CFO Chief Executive Officer | |
| Arizona State University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Arizona | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Graduate Degree Doctorate Degree | |
| University of Illinois | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
| OPKO HEALTH, INC. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
selectION, Inc.
 selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | Biotechnology | Chief Executive Officer Director/Board Member | |
| NEXGEL, INC. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| Boston University School of Law | College/University | Graduate Degree Graduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Gensignia, Inc. | Director of Finance/CFO Director/Board Member | ||
IACTA Pharmaceuticals, Inc.
 IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA. | Medical Specialties | Founder Founder Founder | |
Global Source Ventures LLC
 Global Source Ventures LLC Investment ManagersFinance Global Source Ventures LLC (Global Source Ventures) is a venture capital firm founded in 2011 by Antonius Schuh and Stephen Zaniboni. The firm is headquartered in San Diego, California. | Investment Managers | Founder Founder | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| IMMUNITYBIO, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| CELULARITY INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO President Director/Board Member Corporate Officer/Principal Chief Administrative Officer Chief Operating Officer General Counsel | |
Arcturus Bioscience, Inc.
 Arcturus Bioscience, Inc. Medical SpecialtiesHealth Technology Arcturus Bioscience, Inc. develops laser capture micro dissection instruments and reagents for the analysis of microscopic tissue samples. The private company is based in Carlsbad, CA. The company was founded by Antonius P. Schuh. | Medical Specialties | Director of Finance/CFO Founder |
Statistiques
Internationale
| Etats-Unis | 50 |
| France | 2 |
Sectorielle
| Health Technology | 24 |
| Consumer Services | 14 |
| Finance | 7 |
| Health Services | 4 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 559 |
| Corporate Officer/Principal | 267 |
| Independent Dir/Board Member | 161 |
| Chairman | 113 |
| Chief Executive Officer | 101 |
Relations les plus connectées
| Insiders | |
|---|---|
| Tommy Thompson | 57 |
| Robin Smith | 46 |
| Kok Thay Lim | 43 |
| John Sculley | 39 |
| Jerome Zeldis | 38 |
| Mohsin Meghji | 36 |
| Jane Hsaio | 35 |
| Mahendra Shah | 34 |
| Andrew von Eschenbach | 32 |
| Elizabeth Czerepak | 31 |
| Brent Ahrens | 30 |
| Edgar Lee | 26 |
| Andrew Pecora | 25 |
| Michael Blaszyk | 24 |
| Cam Gallagher | 24 |
